• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Erste Sparinvest - ESPA Stock Biotec

+ Add to Watchlist

BIOTEVA:AV

8,350.00 CZK 0.000.00%

As of 00:59:30 ET on 07/25/2014.

Snapshot for Erste Sparinvest - ESPA Stock Biotec (BIOTEVA)

Year To Date: +14.73% 3-Month: +13.64% 3-Year: - 52-Week Range: 5,952.56 - 8,784.06
1-Month: +1.06% 1-Year: +34.66% 5-Year: - Beta vs MIGUBTEC: -

Mutual Fund Chart for BIOTEVA

No chart data available.
  • BIOTEVA:AV 8,350.00
  • 1M
  • 1Y
Interactive BIOTEVA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BIOTEVA

ESPA Stock Biotec is an open-end investment fund incorporated in Austria. The Fund's objective is long-term capital growth. The Fund invests primarily in equity securities issued by larger biotechnology companies located in the United States, Europe and the Asian Pacific Region. The Fund invests approximately 70% of assets in the US, 25% in Europe and the remainder in Asia.

Inception Date: 12-19-2012 Telephone: +43 (0) 50100-0
Managers: HARALD KOBER
Web Site: www.erste-am.com

Fundamentals for BIOTEVA

NAV (on 2014-07-25) 8,350.00
Assets (M) (on 2014-07-24) 89.28
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for BIOTEVA

Dividend Type Omitted
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for BIOTEVA

Front Load -
Back Load -
Current Mgmt Fee -
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for BIOTEVA

Filing Date: 02/28/2014
Name Position Value % of Total
Biogen Idec Inc 30,000 7,539,963 8.416%
Gilead Sciences Inc 109,550 6,697,992 7.477%
Celgene Corp 107,900 6,375,103 7.116%
Amgen Inc 66,580 5,989,596 6.686%
Regeneron Pharmaceuticals Inc 22,740 5,626,868 6.281%
Illumina Inc 32,170 4,187,990 4.675%
Alexion Pharmaceuticals Inc 30,250 4,065,835 4.538%
Vertex Pharmaceuticals Inc 66,500 4,042,057 4.512%
Mylan Inc/PA 72,820 2,994,980 3.343%
BioMarin Pharmaceutical Inc 47,950 2,918,741 3.258%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil